ChemicalBook > Product Catalog >API >Drug metabolism >Garetosmab

Garetosmab

Garetosmab Suppliers list
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840
Email: psaitong@jm-bio.com

Garetosmab manufacturers

  • Garetosmab
  • Garetosmab pictures
  • $787.00
  • 2026-08-20
  • CAS:2097125-54-5
  • Purity: 95.00%
  • Supply Ability: 10g
Garetosmab Basic information
Product Name:Garetosmab
Synonyms:Garetosmab;Research Grade Garetosmab (DHC33101);REGN 2477;Research Grade Garetosmab
CAS:2097125-54-5
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Garetosmab Structure
Garetosmab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Garetosmab Usage And Synthesis
UsesGaretosmab (REGN 2477) is a fully human IgG4 monoclonal antibody that specifically inhibits activin A. Garetosmab can be used for fibrodysplasia ossificans progressiva (FOP) research[1].
References[1] Frédéric Vanhoutte, et al. Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti-Activin A): Results From a First-in-Human Phase 1 Study. J Clin Pharmacol. 2020 Nov;60(11):1424-1431. DOI:10.1002/jcph.1638
Garetosmab Preparation Products And Raw materials
Tag:Garetosmab(2097125-54-5) Related Product Information
Flanvotumab Frexalimab Unii-9927mt646m Vadastuximab Levilimab Adintrevimab Ulenistamab Pateclizumab Risankizumab Alsevalimab